Synaffix Expands Partnership Horizon with Boehringer Ingelheim
January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
MORE NEWS
July 22, 2026 - 08:55
New Mexico makes progress to become quantum technology hubNew Mexico is pouring millions of dollars into its bid to become a leading center for quantum technology, and state officials say the effort is showing real results. Quantum technology, which uses...
July 21, 2026 - 18:54
Special Delivery: Drone Technology in Our StateLouisiana is positioning itself as a leader in welcoming new and emerging technologies. From Waymos learning the streets of New Orleans, to space satellites delivering high speed internet to rural...
July 21, 2026 - 10:02
AI Predicts Subway Door Accidents with 97% Accuracy Using Single Camera FrameA new artificial intelligence system promises to prevent subway door entrapment accidents by predicting risky passenger behavior before it happens. The technology analyzes a single frame from...
July 20, 2026 - 23:48
Netflix exec: All employees should aspire to 'AI fluency'Netflix`s chief technology officer, Elizabeth Stone, has made it clear that understanding artificial intelligence is no longer optional for anyone working at the streaming giant. In a recent...